Showing results (831-840 of 866) with videos related to
Sort By:
Pageof 87
The Journal of Chemical Physics|May 1, 2025
Distinguishing packing configurations of molecular dimers using excited-state absorption peaks in two-dimensional electronic spectraMatthew S Barclay, Paul D Cunningham, Gissela Pascual, et al.The British Journal of Surgery|September 29, 2020
Adjuvant therapy following oesophagectomy for adenocarcinoma in patients with a positive resection marginR K Bott, K Beckmann, J Zylstra, et al.International Urogynecology Journal|September 10, 2025
Cross-Sectional Associations of Depressive Symptoms, Anxiety Symptoms, and Emotional Support Seeking with Lower Urinary Tract Symptoms and Bladder HealthSonya S Brady, Deepa R Camenga, Tamera Coyne-Beasley, et al.Neurourology and Urodynamics|October 4, 2019
I never knew anyone who peed on themselves on purpose: Exploring adolescent and adult women's lay language and discourse about bladder health and functionBeverly Rosa Williams, Jesse Nodora, Diane K Newman, et al.British Journal of Cancer|March 18, 2004
Oral capecitabine vs intravenous 5-fluorouracil and leucovorin: integrated efficacy data and novel analyses from two large, randomised, phase III trialsE Van Cutsem, P M Hoff, P Harper, et al.British Journal of Haematology|May 26, 2025
The role of PET/CT in peripheral T-cell lymphoma: Results from the PET/CT substudy of the UK NCRI phase 2 CHEMO-T trialM Gleeson, C Gonzalez Arias, D Cunningham, et al.British Journal of Cancer|March 10, 2001
Alpha-interferon does not increase the efficacy of 5-fluorouracil in advanced colorectal cancerP Thirion, P Piedbois, M Buyse, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2017
Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphomaM Dreyling, F Morschhauser, K Bouabdallah, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancerJ Y Douillard, S Siena, J Cassidy, et al.British Journal of Cancer|May 9, 2013
Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factorsR Cooke, M E Jones, D Cunningham, et al.Pageof 87